NYSE · Drug Manufacturers - General

OGN (OGN) Stock

$13.52 -0.11% NYSE: OGN Healthcare

Valuation

MetricValue
Price$13.52
Market Cap$3.55B
P/E Ratio18.64
P/B Ratio4.69
P/S Ratio0.57
EPS (TTM)$0.72
52-Week High$13.59
52-Week Low$5.69
Dividend Yield0.60%

Financials & Margins

MetricValue
ROE24.87%
ROA1.45%
ROCE170.88%
Gross Margin20.67%
Operating Margin20.67%
Net Margin3.99%
Debt/Equity9.49
Current Ratio1.82

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.3B$6.2B$6.3B$6.4B$6.2B
Operating Profit$1.9B$1.7B$1.3B$1.5B$1.3B
Net Profit$1.4B$917.0M$1.0B$864.0M$187.0M
EPS$5.33$3.59$3.99$3.33$0.72
Op Margin30.4%27.6%21.2%23.2%20.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.7B$11.0B$12.1B$13.1B$12.9B
Total Liabilities$12.2B$11.8B$12.1B$12.6B$12.1B
Cash$737.0M$706.0M$693.0M$675.0M$574.0M
Borrowings$9.4B$9.1B$8.9B$9.0B$8.8B

Latest News

Organon (OGN) Names A Canada Chief, Is The Stock Cheap? Simply Wall St. · Jul 23, 2026 ORGANON CANADA ANNOUNCES THE APPOINTMENT OF DOMINIC BÉGIN AS PRESIDENT AND MANAGING DIRECTOR CNW Group · Jul 22, 2026 OGN: What does Argus have to say about OGN? Argus Research · Jul 22, 2026 Organon to Report Second Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing Business Wire · Jul 16, 2026 Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.5B$858.0M$799.0M$939.0M$700.0M
Investing Cash Flow$-969.0M$-847.0M$-521.0M$-864.0M$-552.0M
Financing Cash Flow$-9.0B$-35.0M$-17.0M$-60.0M$-15.0M
Net Cash Flow$667.0M$-31.0M$-13.0M$-18.0M$-101.0M
Free Cash Flow$2.0B$431.0M$538.0M$588.0M$538.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA7.17
FCF Yield17.42%
Quick Ratio1.42
Interest Coverage2.55
Return 1Y38.95%
Return 3Y-27.47%
Return 5Y-44.31%

Ownership

Insiders Held0.47%
Institutions Held77.70%
Institutions Float Held78.06%
Institutional HolderSharesReport Date
Blackrock Inc.31,717,0282026-03-31
Vanguard Portfolio Management LLC21,846,0362026-03-31
Vanguard Capital Management LLC11,737,0182026-03-31
State Street Corporation9,956,7742026-03-31
LSV Asset Management7,259,7302026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALVOAlvotech $3.16 +3.10% -10.76 $1.07B 0.00%
AUPH $15.00 -1.19% 7.46 $1.93B 0.00%
AVDLAvadel Pharmaceuticals plc $21.64 +0.00% 431.08 $2.12B 0.00%
GRDN $43.83 +11.05% 45.92 $2.78B 0.00%
HRMY $38.24 -1.39% 11.23 $2.21B 0.00%

About OGN

OGN stock trades at $13.52 with a market capitalization of $3.55B. The stock is valued at a price-to-earnings (P/E) ratio of 18.64, price-to-book of 4.69, price-to-sales of 0.57. Over the past 52 weeks the stock has ranged between $5.69 and $13.59, and currently trades at its 52-week high. It pays a dividend yielding 0.60%.

On profitability, OGN generates a return on equity (ROE) of 24.87% — well above the market average, a sign of a high-quality business, return on capital employed of 170.88%, an operating margin of 20.67%, a net profit margin of 3.99%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides